$59.28−0.74 (−1.23%)
At close: Nov 17, 2026, 4:00 PM ET· NYSE · USD
Ingevity (NGVT) Income Statement
Is this a real, growing, cash-generative business, or a story propped up by accounting?
Sources Company filings FilingsHow we compute thisNot investment advice
Business engineChoppy: revenue is 30% below its peak, net margin −14.3%.
The four lines that matter · FY21–FY25
Revenue ($M)▼2.7%
1,167.6
FY21→FY25CAGR −4.3%/yr
Net income ($M)▲61.2%
−167.1
one-off year: see footnoteCAGR —
Free cash flow ($M)▲436.3%
273.5
FY21→FY25CAGR +9.6%/yr
Diluted EPS▲61.1%
−4.61
buyback-liftedCAGR —
What the receipts whisper · what a headline number hides
Share count
−9.5%
39.0mn → 35.3mn diluted shares since FY21. Part of EPS growth is the shrinking denominator. Watch net income too.
Capex
$57.7M
−25.6% YoY in FY25 · 4.9% of revenue.
What the income statement says · FY21–FY25
Where every revenue dollar goes · FY25 ($M)
-14¢ of every revenue dollar becomes profit. The biggest cost lever is COGS.
Margin trend · direction beats level Gross Operating Net
Over this window: gross 36.9% → 39.5%. Net margin -14.3% is below the sector median.
The receipt · income statement · FY21–FY25 USD millions except per-share & ratios · hover a line for its definition
USD millions except per-share & ratios
| Line item | TTM † | FY25 | FY24 | FY23 | FY22 | FY21 | YoY | CAGR 21→25 |
|---|---|---|---|---|---|---|---|---|
| Revenue & profitability | ||||||||
Revenue | 1,132.3 | 1,167.6 | 1,200.1 | 1,215.5 | 1,668.3 | 1,391.5 | ▼2.7% | −4.3% |
Cost of revenue | 656.2 | 706.1 | 735.3 | 770.5 | 1,098.2 | 878.7 | ▼4.0% | −5.3% |
Gross profit | 476.1 | 461.5 | 464.8 | 445.0 | 570.1 | 512.8 | ▼0.7% | −2.6% |
Research & development | 28.5 | 28.4 | 24.5 | 25.4 | 30.3 | 26.3 | ▲15.9% | +1.9% |
Selling, general & admin | 159.4 | 171.2 | 157.8 | 161.8 | 198.8 | 179.3 | ▲8.5% | −1.1% |
Total operating expenses | 330.3 | 505.5 | 507.3 | 244.2 | 246.2 | 222.4 | ▼0.4% | +22.8% |
Operating incomefeeds ROC rank | 145.8 | −44.0 | −42.5 | 200.8 | 323.9 | 290.4 | ▼3.5% | — |
Other income, net | −101.3 | −98.1 | −98.0 | −70.8 | −54.3 | −127.6 | — | — |
Pretax income | 44.5 | −142.1 | −140.5 | 130.0 | 269.6 | 162.8 | ▼1.1% | — |
Income tax | 9.0 | 8.2 | −19.1 | 24.2 | 58.0 | 44.7 | — | −34.6% |
Net incomePiotroski ROA ✕feeds Buffett Quality owner earnings | 59.8 | −167.1 | −430.3 | −5.4 | 211.6 | 118.1 | ▲61.2% | — |
| Per share | ||||||||
Diluted EPSbuyback-sensitive | 1.74 | −4.61 | −11.85 | −0.15 | 5.50 | 2.95 | ▲61.1% | — |
Diluted shares (mn) | 33.78 | 35.29 | 36.35 | 36.24 | 37.15 | 39.00 | ▼2.9% | −2.5% |
| Margins | ||||||||
Gross margin73rd pct in Basic Materials | 42.0% | 39.5% | 38.7% | 36.6% | 34.2% | 36.9% | ▲0.8pp | +2.7pp |
Operating margin | 12.9% | −3.8% | −3.5% | 16.5% | 19.4% | 20.9% | ▼0.2pp | −24.6pp |
Net margin4th pct in Basic Materials | 5.3% | −14.3% | −35.9% | −0.4% | 12.7% | 8.5% | ▲21.5pp | −22.8pp |
† TTM = trailing four quarters through 2026-09-30.FY21 effective tax rate was 27% vs a 19% norm for this window, likely a one-time item; see the filing.FY25 effective tax rate was −6% vs a 19% norm for this window, likely a one-time item; see the filing.
5 more years of statements and CSV export are on Premium, and 7 more on Ultimate.Premium · $119/yr · 7-day trial · cancel anytimeUnlock with Premium →
These lines feed the tenet checklists: see which gates passTenets →Margins & returns continue as sector-ranked ratiosStatistics →
Annual report filed 2026-02-26 · view filings on SEC EDGAR ↗ · reported currency USD · as-filed figures may be later restated.
Statements normalized in our fundamentals DB · Not investment advice.
Statements normalized in our fundamentals DB · Not investment advice.
Common questions
What was Ingevity's revenue last fiscal year?
Ingevity reported revenue of $1,167.6M in fiscal 2025, down 2.7% from fiscal 2024.
What was Ingevity's net income?
Ingevity reported net income of −$167.1M in fiscal 2025, a net margin of −14.3%.
Annual and quarterly statements as filed, normalized into one comparable shape · Not investment advice.

